1. Home
  2. HUBC vs SER Comparison

HUBC vs SER Comparison

Compare HUBC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hub Cyber Security Ltd.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.37

Market Cap

25.0M

Sector

N/A

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.13

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBC
SER
Founded
2017
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0M
29.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HUBC
SER
Price
$0.37
$2.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
2.3M
25.0K
Earning Date
05-01-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,966,000.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$1.71
52 Week High
$14.00
$7.92

Technical Indicators

Market Signals
Indicator
HUBC
SER
Relative Strength Index (RSI) 26.43 29.30
Support Level $0.35 $1.71
Resistance Level $0.44 $2.21
Average True Range (ATR) 0.06 0.25
MACD 0.03 -0.02
Stochastic Oscillator 35.66 31.06

Price Performance

Historical Comparison
HUBC
SER

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: